Ignite Creation Date:
2024-05-06 @ 10:08 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03172208
Status:
COMPLETED
Last Update Posted:
2017-11-14
First Post:
2017-05-29
Brief Title:
Caplacizumab Single and Multiple Dose Study in Healthy Japanese and White Subjects
Sponsor:
Ablynx a Sanofi company
Organization:
Ablynx a Sanofi company
Organization Data
Organization:
Ablynx a Sanofi company
Class:
INDUSTRY
Study ID:
ALX0681-C103
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ablynx a Sanofi company
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None